Martha B. Koo, MD

Martha B. Koo, MD

LFAPA · FCTMSS · FASAM
Psychiatrist · Addiction Medicine Specialist · Psychoanalyst
Manhattan Beach, California
17
years pioneering
TMS
5
peer-reviewed
publications
60+
media
appearances
28+
facilities
under CMO oversight

Dr. Martha B. Koo, M.D., LFAPA, FCTMSS, FASAM, is a board-certified psychiatrist, addiction medicine specialist, psychoanalyst, and certified psychedelic-assisted therapist.

She completed undergraduate studies at Princeton University, medical training at the David Geffen School of Medicine at UCLA, psychiatry residency at the UCLA Semel Institute for Neuroscience and Human Behavior, psychoanalytic training at the New Center for Psychoanalysis, psychedelic-assisted therapy certification with the California Institute of Integral Studies, and the MAPS MDMA Therapy Training Program for MDMA-assisted therapy for PTSD.

For three decades, Dr. Koo has practiced outpatient psychotherapy, psychoanalysis, and pharmacological treatment. A pioneer in the development and application of Transcranial Magnetic Stimulation (TMS), she opened Southern California's first private TMS center in 20091 — which evolved into Neuro Wellness Spa — and went on to serve as President of the Clinical TMS Society (2024–2025)2.

She is a Founder and Chief Medical Officer at Neuro Wellness Spa3. With a strong background in human psychodynamics, psychological theory, psychiatric medicine, and neuroscience, Dr. Koo has dedicated her career to community, academic, and professional advocacy for the advancement of psychiatric treatment — to increase access and awareness of the most effective, personalized mental health interventions.

She is a passionate advocate for the use of novel treatment interventions for mental health. In her free time, Dr. Koo enjoys yoga, chess, playing the violin, hiking, and travel.

Explore her credentials and leadership, peer-reviewed research, original insights, published article archive, and recent speaking and media appearances.

"You've got to do it. I don't know how you can perceive a future in the field of psychiatry without integrating neuromodulatory techniques."

— Osmind: Psychiatry Tomorrow

Currently Leads

9 active board, executive, and faculty roles · full leadership history →
Board of Directors, Clinical TMS Society
Past President, Clinical TMS Society (2024–2025)
Board of Directors, FACTMS
Board of Directors, Your Behavioral Health
Chief Medical Officer, Your Behavioral Health
Faculty, PULSES — The Clinical TMS Society Training Course
Board of Directors, Beach Cities Health District (2020–2028)
Medical Advisor, Osmind
Clinic Advisory Board, Magellan Health · Optum

Recent Peer-Reviewed Work

2 of 5 publications in Brain Stimulation · all research →
Koo, M. (May–Jun 2023). The potential of transcranial magnetic stimulation as a treatment for depression during pregnancy. Brain Stimulation, 16, 734–736.
Goldman, P., Pedersen, E., Bailey, M., Hasse, M., Koo, M. (May–Jun 2022). Age as a determinant of transcranial magnetic stimulation efficacy for major depressive disorder. Brain Stimulation, 15(3).
View all research →

Most Recent Appearances

3 of 60+ talks, podcasts, and articles · browse all →
Becker's Hospital Review — CEO + CFO Roundtable (2026)
Osmind: Psychiatry Tomorrow — How TMS is Rewiring Psychiatry
Psychology Today — "Revolutionizing Addiction Recovery"
Full media inventory →